Canadian Medical Association Journal
Anecdotal reports of efficacy from patients who use medical marijuana aren’t enough to convince many physicians that cannabis is a viable therapeutic option, but new industry-funded research in Canada may bring some science to the situation.
THE GLOBE AND MAIL
Tilray announced Thursday it has teamed up with researchers at the University of British Columbia’s Okanagan campus to conduct the first clinical trial in Canada to test the impact of medicinal marijuana on PTSD sufferers.
BUSINESSWIRE
Pending regulatory approvals, the UBC-Tilray study is poised to be one of the first in the world to run a large-scale clinical trial examining medical cannabis as a treatment for a mental health disorder.
VANCOUVER SUN
A B.C. medical marijuana producer is seeking approval from Health Canada to sponsor the first study in Canada on the safety and effectiveness of cannabis for post-traumatic stress disorder (PTSD) among sexual assault victims, military veterans and first responder personnel.
